Alphadyne Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
VCM
N
Alphadyne Asset Management's REGN Position: Q1 2026 in Review
Alphadyne Asset Management opened a new position in Regeneron Pharmaceuticals (REGN) in Q1 2026: 754 shares worth $583K. The stake represents 0.01% of the portfolio and ranks #666 among its holdings. This is a return to the name: Alphadyne Asset Management previously reported a position in REGN as recently as Q3 2025.
Alphadyne Asset Management first reported a position in REGN in Q3 2023 and has held it in 3 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Alphadyne Asset Management held 754 shares of Regeneron Pharmaceuticals worth $583K as of Q1 2026.
- Regeneron Pharmaceuticals was a new Alphadyne Asset Management position in Q1 2026.
- Regeneron Pharmaceuticals made up 0.01% of Alphadyne Asset Management's portfolio in Q1 2026, its #666 holding.
- Alphadyne Asset Management first reported a position in Regeneron Pharmaceuticals in Q3 2023 and has held it in 3 quarters since.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Alphadyne Asset Management's 13F filing for Q1 2026, filed 15 May 2026.